Pharmaceuticals, Biotechnology and Life Sciences
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system.
Vetter Pharma has announced additional investments of €230 million in its new production building, which is currently under construction at the company’s global corporate headquarters site in Ravensburg, as it has recently reached a significant milestone in the construction process, as the shell of the building is now complete, following the start of construction in November 2021.
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), have announced that the companies are unveiling Xpert Alliance, a joint visualization of their strategic collaboration.
Vetter and Rentschler Biopharma have announced joining forces to boost their services and along the biopharmaceutical value chain.
Seal of quality for outstanding corporate management Analysis of the areas of strategy, innovation, corporate culture and finance Comprehensive three-stage…